Organization | Qingdao Municipal Hospital

Qingdao Municipal Hospital Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4

Founded: Qingdao China (1916)

Organization Overview

First Clinical Trial

2014

NCT02241629

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

Qingdao Municipal Hospital | Qingdao Municipal Hospital (Group)

Active Ingredients

Drugs in Phase 4 Trials (9)

andrographolide (1 trial)

azithromycin (zithromax) (1 trial)

budesonide (rhinocort) (1 trial)

cephalosporin (1 trial)

clavulanate (Augmentin) (1 trial)

doxycycline (vibramycin) (1 trial)

fluoroquinolone (1 trial)

minocycline (minocin) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

Drugs in Phase 2 Trials (6)

apatinib (1 trial)

gimeracil (1 trial)

levo phencynonate hydrochloride (1 trial)

oteracil (1 trial)

tegafur (1 trial)

Drugs in Phase 1 Trials (1)

pazufloxacin (1 trial)

Drugs in Other Trials (2)

oseltamivir (tamiflu) (1 trial)

xiyanping (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Motion Sickness (Phase 2)

Otitis (Phase 1)

Otitis Media (Phase 1)

Pneumonia (Phase 4)

Stomach Neoplasms (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 6
# of Trial APIs: 18